An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...

Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that ...

The Food and Drug Administration, making good on a Trump administration promise to examine the usage of antidepressants, on ...

A member of a B.C. committee who abruptly resigned last week after the province reinstated drug funding for a girl with a ...

Hormone therapies for menopause have come with black box warnings for decades. Our wellness expert explains why this could ...

Among reasons for the rejection, the agency cited a lack of US patient representation in the STARGLO trial assessing ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing ...

An organization doesn't have to be founded with a religious purpose to claim protection under the country's laws governing ...

The Patented Medicine Prices Review Board’s mandate is to make sure that drug prices are not excessive. However, new guidelines that change criteria for assessing prices may lead to higher prices.

The new target action date for Blenrep, which GSK is proposing for the second-line treatment of relapsed or refractory multiple myeloma, is Oct. 23.

Among the Russian intelligence was what Gabbard described as “high-level Democratic National Committee emails that detailed ...